Cargando…

Tildrakizumab: Successful Response in Two Patients With Psoriatic Arthritis

Detalles Bibliográficos
Autores principales:	Buononato, Dario, Licata, Gaetano, Gambardella, Alessio, De Rosa, Alina, Calabrese, Giulia, Argenziano, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mattioli 1885 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116554/ https://www.ncbi.nlm.nih.gov/pubmed/35646471 http://dx.doi.org/10.5826/dpc.1202a49

Ejemplares similares

Topical and Conventional Systemic Treatments in Atopic Dermatitis: Have They Gone Out of Fashion?
por: Calabrese, Giulia, et al.
Publicado: (2022)

CMV Infection: A Clinical Challenge in Biological Therapy? The Case of Asymptomatic Patients with Persistent Positive Immunoglobulin M Anti-CMV Treated with Secukinumab
por: Gambardella, Alessio, et al.
Publicado: (2020)

Effectiveness and Safety After a Switch to Tildrakizumab: A Real World Multicenter Italian Study in Psoriasis
por: Di Brizzi, Eugenia Veronica, et al.
Publicado: (2023)

Evaluation of the Role of Faecal Calprotectin in the Management of Psoriatic Patients under Treatment with Biologic Drugs
por: Di Brizzi, Eugenia Veronica, et al.
Publicado: (2022)

A Real-Life Study on the Use of Tildrakizumab in Psoriatic Patients
por: Campione, Elena, et al.
Publicado: (2023)

The optimal use of tildrakizumab in the elderly via improvement of Treg function and its preventive effect of psoriatic arthritis
por: Fukasawa, Takemichi, et al.
Publicado: (2023)

Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?
por: Megna, Matteo, et al.
Publicado: (2021)

A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with Tildrakizumab
por: Damsin, Thomas
Publicado: (2023)

Successful treatment of acrodermatitis continua of Hallopeau with tildrakizumab: A case report
por: Nguyen, Alex, et al.
Publicado: (2023)

Erythrodermic psoriasis improved by Tildrakizumab
por: Trevisan, Giampaolo, et al.
Publicado: (2022)

Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
por: Barbarroja, Nuria, et al.
Publicado: (2019)

Tildrakizumab in the treatment of psoriasis – literature review
por: Banaszczyk, Katarzyna
Publicado: (2019)

Tildrakizumab ineffective in generalized granuloma annulare
por: Song, Eingun James
Publicado: (2020)

Efficacy and safety of tildrakizumab in patients with active psoriatic arthritis: results of a randomised, double-blind, placebo-controlled, multiple-dose, 52-week phase IIb study
por: Mease, Philip J, et al.
Publicado: (2021)

Incidence of serious gastrointestinal events among tildrakizumab‐treated patients with psoriasis: Letter to the Editor
por: Gooderham, M., et al.
Publicado: (2019)

A case of severe psoriatic arthritis with hands flexion contracture and palmar psoriasis successfully treated with guselkumab
por: Megna, Matteo, et al.
Publicado: (2022)

Brodalumab in the treatment of psoriatic arthritis – the latest reports
por: Banaszczyk, Katarzyna
Publicado: (2021)

Tildrakizumab in the treatment of psoriasis: latest evidence and place in therapy
por: Pithadia, Deeti J., et al.
Publicado: (2019)

Assessment of the effects of immunogenicity on the pharmacokinetics, efficacy and safety of tildrakizumab
por: Kimball, A.B., et al.
Publicado: (2019)

Clearance of head and neck involvement in plaque psoriasis with tildrakizumab treatment in the phase 3 reSURFACE 1 study
por: Menter, M.A., et al.
Publicado: (2020)

Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report
por: Leow, Liang Joo, et al.
Publicado: (2022)

Tildrakizumab in moderate‐to‐severe plaque psoriasis: A multicenter, retrospective, real‐life study
por: Caldarola, Giacomo, et al.
Publicado: (2022)

Dose Adjustment of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in the Real World: A Systematic Review
por: Gambardella, Alessio, et al.
Publicado: (2021)

Efficacy and Safety of Tildrakizumab in a Patient with Chronic HBV Infection
por: Potestio, Luca, et al.
Publicado: (2023)

Trials and tribulations in managing a complex case of psoriatic arthritis—a success story in the real world
por: Devarakonda, Aneela, et al.
Publicado: (2021)

Pharmacogenetics of Treatment Response in Psoriatic Arthritis
por: Jani, Meghna, et al.
Publicado: (2015)

Psoriatic arthritis
por: Sankowski, Artur Jacek, et al.
Publicado: (2013)

Psoriatic Arthritis
por: Fitzgerald, Kara, et al.
Publicado: (2012)

Psoriatic arthritis
por: Ocampo D, Vanessa, et al.
Publicado: (2019)

Psoriatic Arthritis That Responded Dramatically When Infliximab Was Switched to Adalimumab
por: Ohshima, Yuichiro, et al.
Publicado: (2013)

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

A qualitative study of patients’ experiences of screening for psoriatic arthritis
por: Silverthorne, Christine A., et al.
Publicado: (2022)

Successful treatment with secukinumab in an HIV‐positive psoriatic patient after failure of apremilast
por: Romita, Paolo, et al.
Publicado: (2022)

Effective and Safe Treatment of Psoriatic Disease with the Anti-IL-23p19 Biologic Tildrakizumab: Results of a Real-World Prospective Cohort Study in Nonselected Patients
por: Drerup, Katharina A., et al.
Publicado: (2022)

Treatment of moderate-to-severe plaque psoriasis with tildrakizumab in the real-life setting
por: Burlando, Martina, et al.
Publicado: (2021)

Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis
por: Trídico, Lívia Arroyo, et al.
Publicado: (2017)

Replication of a distinct psoriatic arthritis risk variant at the IL23R locus
por: Budu-Aggrey, Ashley, et al.
Publicado: (2016)

A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab
por: Bernardini, Nicoletta, et al.
Publicado: (2022)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
por: Elliott, Ashley, et al.
Publicado: (2019)

New Insights on Juvenile Psoriatic Arthritis
por: Brunello, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_grqr6vv02d036fla2cib8nn43u